running on [gasdermin] e: gasdermin e stabilizes egfr to drive lung cancer
Published 1 year ago • 45 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
32:40
a tyrosine kinase protein interaction map reveals targetable egfr network oncogenesis in lung cancer
-
0:43
dr. jackman on overcoming resistance to egfr inhibitors in lung cancer
-
0:47
remaining areas of unmet need for patients with locally advanced pancreatic cancer
-
4:56
active trial update: egfrm nsclc
-
0:56
fueling discovery
-
0:20
preview: dr. gainor on clinical trials
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
2:02
stage 4 colorectal cancer thriver is running for research
-
3:31
vegf targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma
-
3:24
2020 ttf egfr session qa panel srt with osimertinib (tagrisso) first line, stable disease
-
2:23
prolaris - not all cancers are the same
-
3:01
genomic landscape of late-stage gastric cancer treated with pembrolizumab
-
39:49
webinar: elevating precision medicine to the forefront of every cancer journey
-
5:24
the hunt for new checkpoint inhibitors - amgen science
-
2:01
frank gertler discusses mena, new cancer test possibilities
-
3:46
should i get genetic testing for kidney cancer?
-
0:30
preview: dr. gainor on pd-l1 testing
-
10:24
prostate cancer and early detection: should we follow the nccn guidelines?
-
3:48
pancreatic cancer alliance launch - the hon jillian skinner, mp